Streetbeat News

Equity Actions

UTZ

Utz Brands (NYSE:UTZ) received a mix of analyst ratings over the last quarter, with 1 bullish, 7 somewhat bullish, and 3 indifferent. The average 12-month price target among 11 analysts is $16.18, with a high of $19.00 and a low of $13.00. Analysts have decreased the average price target by 13.84%. Key analysts from firms like Piper Sandler, RBC Capital, and Goldman Sachs have adjusted their ratings and price targets, reflecting their views on the company's performance and market conditions. Utz Brands is a snack food manufacturer with a diverse product portfolio and has shown a positive revenue trend with a growth rate of 2.49% as of September 30, 2023.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:39 pm

WELL

Welltower (NYSE:WELL) received 9 analyst ratings in the last quarter, with an average 12-month price target of $93.22, a high of $101.00, and a low of $83.00. The current average reflects a 3.91% increase from the previous average of $89.71. Analysts from firms like JP Morgan, RBC Capital, and Raymond James have raised their price targets, indicating a positive sentiment towards Welltower's stock. The company has shown a positive revenue trend with a growth rate of 12.77% as of September 30, 2023, but has a net margin and ROE below industry averages, although its ROA and debt management are strong.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:39 pm

AAPL

Apple Inc. has seen its market cap grow by $1 trillion in 2023, surpassing $3 trillion. Analysts predict a potential rise to $4 trillion by end of 2024. Apple's stock hit record highs, recovering from a 15% drop to an 18% gain, and is now approaching the $200 level. The stock closed at $198.11 on December 14.

Portfolio Pulse from Zaheer Anwari

December 18, 2023 | 3:32 pm

REGN

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw a 0.99% decrease in stock price to $850.63 in the current market session. Despite this, REGN's stock has risen by 6.48% over the past month and 15.96% over the past year. The article discusses the P/E ratio of REGN in comparison to its industry peers, suggesting that while REGN has a lower P/E than the Biotechnology industry average, this could indicate that the stock is undervalued rather than underperforming.

Portfolio Pulse from Benzinga Insights

December 18, 2023 | 3:15 pm

AAPL

Investor Business Daily's SwingTrader has reportedly sold shares of Apple (AAPL), which may indicate a shift in their trading strategy or response to market conditions.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:58 pm

CLF

Cleveland-Cliffs, Inc. (NYSE:CLF) stock is trading higher after the company commented on the proposed acquisition of U.S. Steel by Nippon Steel. CEO Lourenco Goncalves highlighted U.S. Steel's undervaluation and synergy potential with Cleveland-Cliffs, expressing that the sector is undervalued and a re-rating for Cleveland-Cliffs is overdue. The company has reached its net debt target and plans to prioritize aggressive share buybacks. CLF shares have risen 19% over the past month and are up 8.8% at $20.34.

Portfolio Pulse from Erica Kollmann

December 18, 2023 | 2:57 pm

YQ

17 Education & Technology Group Inc (NASDAQ:YQ) stock is trading lower at $1.56 after announcing a change in the ratio of its ADSs to Class A ordinary shares from 1:10 to 1:50, effectively a one-for-five reverse ADS split. Fractional ADSs will not be issued; instead, they will be sold and proceeds distributed to holders.

Portfolio Pulse from Henry Khederian

December 18, 2023 | 2:46 pm

VVPR

VivoPower International PLC's Executive Chairman and CEO, Kevin Chin, is set to increase his shareholding in the company by 125,000 shares, which is about 4% of the company's undiluted shares. This increase comes as a result of Chin opting to receive his CEO salary in the form of VivoPower shares since July 1, 2023, a decision approved by the Remuneration Committee. The share issuance is contingent on the directors being granted authority to allot shares by shareholders at the 2023 Annual General Meeting.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:35 pm

CLF

X

Cleveland-Cliffs' CEO Lourenco Goncalves commented on the proposed acquisition of U.S. Steel by Nippon Steel, expressing that U.S. Steel's decision validates Cleveland-Cliffs' view of the undervaluation in the steel sector. Goncalves highlighted Cleveland-Cliffs' achievement of its net debt target and announced a shift in capital allocation towards more aggressive share buybacks.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:27 pm

COSM

Cosmos Health Inc. CEO, Mr Greg Siokas, plans to buy up to $3M of COSM common shares in the open market by the end of 2024. He has already invested $1M in 2023 and over $15M since inception. Siokas believes the stock is undervalued and sees current prices as an opportunity to increase his stake, especially with the company's growth prospects, R&D initiatives, and potential spinoff of its R&D department.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:19 pm